ci 988 has been researched along with Panic Attacks in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, JB; Costa, J; Cutler, NR; Greiner, M; Pande, AC; Pierce, MW; Pyke, RE; Schweizer, E; Wilcox, CS; Wisselink, PG | 1 |
Adams, JB; Cook, J; Cowley, DS; Pyke, RE; Roy-Byrne, PP; Wingerson, D; Zaccharias, P | 1 |
den Boer, JA; Pande, AC; Slaap, B; van Es-Radhakishun, F; van Megen, HJ; Westenberg, HG | 1 |
Adams, JB; Greiner, M; Lydiard, RB; Pande, AC; Pierce, MW | 1 |
4 trial(s) available for ci 988 and Panic Attacks
Article | Year |
---|---|
A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Colonic Diseases, Functional; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Indoles; Male; Meglumine; Panic Disorder; Personality Inventory; Phobic Disorders; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Somatoform Disorders; Treatment Outcome | 1995 |
Effect of CI-988, a cholecystokinin-B receptor antagonist, on lactate-induced panic.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Heart Rate; Humans; Indoles; Lactic Acid; Male; Meglumine; Panic Disorder; Psychiatric Status Rating Scales; Receptors, Cholecystokinin | 1996 |
The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Cross-Over Studies; Double-Blind Method; Female; Humans; Hydrocortisone; Indoles; Male; Meglumine; Middle Aged; Panic Disorder; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Tetragastrin; Treatment Outcome | 1997 |
Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Indoles; Meglumine; Middle Aged; Panic Disorder; Receptors, Cholecystokinin | 1999 |